The vaccines from Biontech / Pfizer and Moderna are said to

New Post Public Reply Private Reply Replies (2) Message Board
SamRogers
555
The vaccines from Biontech / Pfizer and Moderna are said to protect against the coronavirus for years. According to a scientific study in "Nature" magazine, they trigger a sustained immune response in the body. The results support the belief that most people immunized with the mRNA vaccines may not need a booster dose as long as the virus and its variants do not progress much beyond their current forms. However, according to the scientists involved in the study, this is not guaranteed.

"It's a good sign of how durable our immunity is after this vaccine," study leader Ali Ellebedy, immunologist at Washington University in St. Louis, told the New York Times about the results. The vaccine from Johnson & Johnson was not taken into account in the study, but he assumes that the immune response is less permanent than that of mRNA vaccines.

A month ago, a research team led by Ellebedy found that people who had survived Covid disease had immune cells against Sars-CoV-2 in the bone marrow even eight months after the infection. Another study showed that so-called memory B cells remain in the body for at least a year after infection. According to the results, researchers believe that people who were infected and later vaccinated may have a lifetime of producing immune cells against the coronavirus. However, it was unclear whether vaccination alone could have a similar long-lasting effect.

After an infection or vaccination, a specialized structure, the germinal center, forms in the lymph nodes. This structure is the basis for B cells (B lymphocytes), which form antibodies against viruses. The longer these B cells remain in the body, the more effectively they can react to virus variants. Dr. Ellebedy found that 15 weeks after the first dose of the vaccine, the germinal center was still highly active in all 14 participants and that the number of memory cells that recognized the coronavirus had not decreased.

Germ centers usually peak one to two weeks after vaccination and then decrease. "Usually there isn't much left after four to six weeks," Deepta Bhattacharya, an immunologist at the University of Arizona, told the newspaper. But the germinal centers stimulated by the mRNA vaccines barely receded months after vaccination. Most of what scientists know about the persistence of germinal centers is based on animal studies, according to Bhattacharya. The new study shows for the first time what happens to people after vaccination.

According to the study, people who are permanently treated with medication and older people with a weak immune system need a booster vaccination. According to the research group around Ellebedy, it is difficult to predict exactly how long the protection of mRNA vaccines will last. Without variants, immunity could theoretically last a lifetime. But the virus is clearly evolving.

https://www.n-tv.de/panorama/Moderna-und-Bion...50635.html

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 5

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 9

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading

Top 5 Most Recently Viewed Articles

Avricore Health Transitions Strategy to Capitalize on UK Market

Updated Category News Views 131

Avricore Health's Strategic Pivot Towards the UK Market Avricore Health Inc. (TSX-V: AVCR), a pioneer in pharmacy-based point-of-care testing solutions, has announced an exciting strategic shift. The company is refocusing its efforts on the rapidly growing healthcare market in the UK, while gradually winding down its partnership with a prominent Canadian pharmacy chain....

Continue Reading
Lawsuit Against TikTok Sparked by Tragedy of Four Children

Updated Category News Views 347

Tragic Lawsuit Filed Against TikTok and ByteDance The Social Media Victims Law Center (SMVLC) has stepped forward as a legal advocate for the heartbreaking case of four families from the United Kingdom. These families are seeking justice through a wrongful death lawsuit against TikTok Inc. and its parent company ByteDance Inc. Their tragic stories link back to the allure...

Continue Reading
Revolutionizing Insurance: Shift Technology's New Data Network

Updated Category News Views 336

Empowering Insurers Through Collaborative Data Sharing Shift Technology, known for its innovative AI-powered solutions for the insurance sector, has recently introduced the Insurance Data Network (IDN). This breakthrough network is designed to revolutionize how insurers share data and insights, fostering a collaborative environment for improved outcomes. What is the...

Continue Reading
Jeff Marek Joins The Nation Network with New Hockey Show

Updated Category News Views 251

Exciting Launch of The Sheet with Jeff Marek Toronto has witnessed the expansion of hockey coverage through the innovative initiative by The Nation Network. This new venture, known as The Sheet, is hosted by the esteemed broadcaster Jeff Marek. With his notable presence in the hockey community, Marek aims to elevate the experience for hockey enthusiasts by integrating...

Continue Reading
Join Class Action for West Pharmaceutical Services, Inc. Today

Updated Category News Views 166

Join the Class Action Against West Pharmaceutical Services, Inc. The Gross Law Firm represents shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). We encourage those who purchased shares during the designated period to reach out for information on lead plaintiff appointments. Understanding the Class Period and Allegations Shareholders acquired during the class...

Continue Reading